|
Originally published In Press as doi:10.1074/jbc.M203623200 on May 24, 2002
J. Biol. Chem., Vol. 277, Issue 32, 28683-28689, August 9, 2002
The Phosphorylation Site Located in the A Region of Retinoic X
Receptor Is Required for the Antiproliferative Effect of
Retinoic Acid (RA) and the Activation of RA Target Genes in F9
Cells*
Julie
Bastien ,
Sylvie
Adam-Stitah ,
Jean-Luc
Plassat,
Pierre
Chambon, and
Cécile
Rochette-Egly§
From the Institut de Génétique et de Biologie
Moléculaire et Cellulaire,
CNRS/INSERM/ULP/Collège
de France, BP 163, 67404 Illkirch Cedex, France
Mouse F9 embryocarcinoma cells constitute
a well established cell autonomous model system for investigating
retinoic acid (RA) signaling in vitro. RA induces the
differentiation of F9 cells grown as monolayers into endodermal-like
cells and decreases their rate of proliferation. Knock-out of the
retinoic X receptor (RXR ) gene abolishes endodermal
differentiation and the induction of several endogenous RA-responsive
genes. RXR null cells are also drastically impaired in their
antiproliferative response to RA. The role of the RXR
phosphorylation site located in the N-terminal A region
(Ser22) has been investigated here by establishing cell
lines re-expressing RXR either wild type or mutated at the
phosphorylation site (RXR S22A) in a RXR -null background. We show
that Ser22 is dispensable for RA-induced endodermal
differentiation but is crucial for the expression of several
RA-responsive genes. Ser22 is also indispensable for the
antiproliferative effect of RA and necessary for the RA-induced
down-regulation of p21CIP and p27KIP
CKIs proteins that are known to be involved in the control of cell cycle progression.
*
This work was supported by funds from CNRS, INSERM, the
Collège de France, the Association pour la Recherche sur le
Cancer, and Bristol-Myers Squibb.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by the Ministère de l'Education Nationale et de
la Recherche Scientifique et Technique.
§
To whom correspondence should be addressed: IGBMC, BP 163, 67 404 Illkirch Cedex, CU de Strasbourg, France. Tel.:
33-3-88-65-34-59; Fax: 33-3-88-65-32-01; E-mail:
cegly@igbmc.u-strasbg.fr.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. B. Cheung, J. Bell, A. Raif, A. Bohlken, J. Yan, B. Roediger, A. Poljak, S. Smith, M. Lee, W. D. Thomas, et al.
The Estrogen-responsive B Box Protein Is a Novel Regulator of the Retinoid Signal
J. Biol. Chem.,
June 30, 2006;
281(26):
18246 - 18256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Narayanan, V. A. T. Sepulveda, M. Falzon, and N. L. Weigel
The Functional Consequences of Cross-talk between the Vitamin D Receptor and ERK Signaling Pathways Are Cell-specific
J. Biol. Chem.,
November 5, 2004;
279(45):
47298 - 47310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Cammas, M. Herzog, T. Lerouge, P. Chambon, and R. Losson
Association of the transcriptional corepressor TIF1{beta} with heterochromatin protein 1 (HP1): an essential role for progression through differentiation
Genes & Dev.,
September 1, 2004;
18(17):
2147 - 2160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Smith, J. L. Smedberg, M. E. Rula, and X.-X. Xu
Regulation of Ras-MAPK pathway mitogenic activity by restricting nuclear entry of activated MAPK in endoderm differentiation of embryonic carcinoma and stem cells
J. Cell Biol.,
March 1, 2004;
164(5):
689 - 699.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|